Leading the advancement in touchless interaction with custom technological solutions. Our deep understanding of user behavior drives us to design intuitive and practical products for diverse medical and industrial sectors.
Leadership Team
As CEO, I am responsible for leadership and operations at NZTech, which includes securing and managing the financing, and making decisions on all strategic activities. My role also extends to cultivating relationships in business, technological and financial spheres to grow business development and productivity.
Creating transformative change in the healthcare sector is my passion. I am constantly exploring new horizons and connecting the technologies we have invented to more practical applications in the medical field.
My passion and drive to develop new technologies – achieved by understanding users’ unmet needs – ensures that we attract highly-skilled experts to our team who have an important contribution to make and who know that something tangible will result from our collaborative efforts.
Board of Directors
As CEO, I am responsible for leadership and operations at NZTech, which includes securing and managing the financing, and making decisions on all strategic activities. My role also extends to cultivating relationships in business, technological and financial spheres to grow business development and productivity.
Creating transformative change in the healthcare sector is my passion. I am constantly exploring new horizons and connecting the technologies we have invented to more practical applications in the medical field.
My passion and drive to develop new technologies – achieved by understanding users’ unmet needs – ensures that we attract highly-skilled experts to our team who have an important contribution to make and who know that something tangible will result from our collaborative efforts.
In addition to her role at Quark Venture, Dr. Wilson is an Advisor and Mentor for Ontario Bioscience's Capital Access Advisory Program, a member of various committees including GlycoNet's Commercialization Committee and Nanomedicines Innovation Network's Research Management Committee. She holds director positions on the boards of Canary Medical, Microbion, IOME, and Crohn's and Colitis Canada, where she chairs the Research Committee. Dr. Wilson is also an Observer on the Boards of ARTMS, Oculogica, and Alpha-9.
Before joining Quark Venture, Dr. Wilson worked as the Associate Director of Partnerships at the Centre for Drug Research and Development (CDRD), where she played a vital role in establishing and maintaining strategic alliances with industry, academia, and government. Her expertise includes drug discovery in the areas of infection, inflammation, and immunity.
Dr. Wilson earned her Ph.D. at the University of British Columbia, specializing in lipid-encapsulated nucleic acids' immunomodulatory activity and vaccine potential. Her achievements during her Ph.D. include prestigious scholarships and awards, such as the Doctoral Research Award from the Canadian Institutes for Health Research and the Gattefosse Canada/Canadian Society for Pharmaceutical Sciences Research Award in 2008.